Search for: "Endo Pharmaceuticals Inc. v. Sandoz Inc."
Results 21 - 31
of 31
Sort by Relevance
|
Sort by Date
4 Apr 2010, 9:55 pm
Endo Pharmaceuticals Inc. 1:10-cv-00261; filed March 31, 2010 in the District Court of Delaware Infringement of U.S. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
10 Feb 2010, 4:47 pm
Sandoz Inc. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/6: Ethicon Endo-Surgery Inc. v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
5 Jul 2007, 10:37 am
App. 1974).Texas: Ethicon Endo-Surgery, Inc. v. [read post]
